ArticleMedical journal of the Islamic Republic of Iran2025
Identification of Important Diagnostic Genes in the Uterine Using Bioinformatics and Machine Learning.
Article in Medical journal of the Islamic Republic of Iran, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Uterine corpus endometrial cancer (UCEC) is known as the sixth most common cancer in the world. Advances in bioinformatics and deep learning have provided the 2 tools for screening large-scale genomic data and discovering potential biomarkers indicative of disease states. This study aimed to investigate the identification of important genes for diagnosis and prognosis in the uterus using bioinformatics and machine learning algorithms. Methods: RNA expression profiles of UECE patients were analyzed to identify differentially expressed genes (DEGs) using deep learning techniques. Prognostic biomarkers were assessed through survival curve analysis utilizing COMBIO-ROC. Additionally, molecular pathways, protein-protein interaction (PPI) networks, co-expression patterns of DEGs, and their associations with clinical data were thoroughly examined. Ultimately, diagnostic markers were determined through deep learning-based analyses. Results: According to our findings, MEX3B, CTRP2 (C1QTNF2), and AASS are new biomarkers for UCEC. The evaluation metrics demonstrate the deep learning model's (DNN) efficacy, with a minimal mean squared error (MSE) of 5.1096067E-5 and a root mean squared error (RMSE) of 0.007, indicative of accurate predictions. The R-squared value of 0.99 underscores the model's ability to explain a substantial portion of the variance in the data. Thus, the model achieves a perfect area under the curve (AUC) of 1, signifying exceptional discrimination ability, and an accuracy rate of 97%. Conclusion: The GDCA database and deep learning algorithms identified 3 significant genes -MEX3B, CTRP2 (C1QTNF2), and AASS-as potential diagnosis biomarkers of UCEC. Thus, identifying new UCEC biomarkers has promise for effective care, improved prognosis, and early diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.